Display options
Cite
Taylor P, Bhatt S, Gouni R, et al. A Case of Propylthiouracil-Induced Hepatitis during Pregnancy. Eur Thyroid J. 2012;1(1):41-4doi: 10.1159/000336071.
Taylor, P., Bhatt, S., Gouni, R., Quinlan, J., & Robinson, T. (2012). A Case of Propylthiouracil-Induced Hepatitis during Pregnancy. European thyroid journal, 1(1), 41-4. https://doi.org/10.1159/000336071
Taylor, Peter, et al. "A Case of Propylthiouracil-Induced Hepatitis during Pregnancy." European thyroid journal vol. 1,1 (2012): 41-4. doi: https://doi.org/10.1159/000336071
Taylor P, Bhatt S, Gouni R, Quinlan J, Robinson T. A Case of Propylthiouracil-Induced Hepatitis during Pregnancy. Eur Thyroid J. 2012 Apr;1(1):41-4. doi: 10.1159/000336071. Epub 2012 Feb 29. PMID: 24782996; PMCID: PMC3821452.
Copy Download .nbib Format: NLM
Share it on

Eur Thyroid J. 2012 Apr;1(1):41-4. doi: 10.1159/000336071. Epub 2012 Feb 29.

A Case of Propylthiouracil-Induced Hepatitis during Pregnancy.

European thyroid journal

Peter Taylor, Sandip Bhatt, Ravi Gouni, Jonathan Quinlan, Tony Robinson

Affiliations

  1. Department of Diabetes and Endocrinology, Royal United Hospital, Bath, Cardiff University School of Medicine, Cardiff, UK ; Department of Centre for Endocrine and Diabetes Sciences, Department of Medicine, Cardiff University School of Medicine, Cardiff, UK.
  2. Department of Gastroenterology, Royal United Hospital, Bath, Cardiff University School of Medicine, Cardiff, UK.
  3. Department of Diabetes and Endocrinology, Royal United Hospital, Bath, Cardiff University School of Medicine, Cardiff, UK.

PMID: 24782996 PMCID: PMC3821452 DOI: 10.1159/000336071

Abstract

A 32-year-old with no pre-existing liver disease was diagnosed with Graves' disease at week 4 of pregnancy. Thyroid-stimulating hormone was undetectable with elevated free thyroxine levels and positive thyroid receptor antibodies. She was started on a reducing regime of propylthiouracil (PTU). At week 20 in pregnancy, she became jaundiced. Initial bloods revealed: bilirubin 91 μmol/l, alanine aminotransferase 1,796 IU/l, alkaline phosphatase 200 IU/l, international normalized ratio 1.2, and albumin 33 g/l. A presumptive diagnosis of PTU-induced hepatitis was made. PTU was immediately discontinued and best supportive care instigated. Serum markers for autoimmune and viral hepatitis were negative, abdomen ultrasound, ferritin and caeruloplasmin were normal. Although her alanine aminotransferase began to fall, her bilirubin continued to rise, peaking at 378. Two weeks after PTU cessation she became thyrotoxic and was started on a reducing regime of carbimazole. Her thyroid function stabilized and liver function tests continued to improve with carbimazole stopped at week 32. Growth scans remained normal with delivery of a healthy baby at 38 weeks. This report highlights that good outcomes can be achieved in PTU-induced hepatitis in pregnancy. Patients on PTU should be warned of the potential risk of hepatic failure and advised to seek medical advice immediately if they develop jaundice.

Keywords: Carbimazole; Hepatitis; Pregnancy; Propylthiouracil

References

  1. Int J Endocrinol. 2010;2010:910636 - PubMed
  2. Thyroid. 2011 Oct;21(10):1081-125 - PubMed
  3. J Clin Endocrinol Metab. 2007 Aug;92(8 Suppl):S1-47 - PubMed
  4. Obstet Gynecol. 1994 Dec;84(6):946-9 - PubMed
  5. Med Clin North Am. 1991 Jan;75(1):121-50 - PubMed
  6. Teratology. 2001 Nov;64(5):262-6 - PubMed
  7. J Clin Endocrinol Metab. 1997 Jun;82(6):1727-33 - PubMed
  8. Liver Transpl. 2004 Aug;10(8):1018-23 - PubMed
  9. J Clin Endocrinol Metab. 2002 Feb;87(2):489-99 - PubMed
  10. Endocrinol Metab Clin North Am. 2006 Mar;35(1):117-36, vii - PubMed
  11. Eur J Gastroenterol Hepatol. 1996 Mar;8(3):287-8 - PubMed
  12. J Clin Endocrinol Metab. 1992 Sep;75(3):738-44 - PubMed
  13. Am J Gastroenterol. 2001 Jan;96(1):165-9 - PubMed
  14. Thyroid. 1994 Spring;4(1):129-33 - PubMed
  15. Endocr Rev. 2010 Oct;31(5):702-55 - PubMed
  16. Br Med Bull. 2011;97:137-48 - PubMed
  17. Thyroid. 2004 Oct;14(10):830-5 - PubMed

Publication Types